CD4 and neoplasm: To further confirm the potential role of IL-21 in mediating chemoimmunotherapy response, we used flow cytometry analysis and demonstrated that CD4+IL21+ cells were significantly higher in MPR tumor tissues than those in treatment-naive and non-MPR tumor tissues (Fig. 3F).